The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?. (2020)

• Record Type: Journal Article
• Authors: Aloizou, Athina-Maria; Pateraki, Georgia; Siokas, Vasileios; Mentis, Alexios-Fotios A.; Liampas, Ioannis; Lazopoulos, George; Kovatsi, Leda; Mitsias, Panayiotis D.; Bogdanos, Dimitrios P.; Paterakis, Konstantinos; Dardiotis, Efthimios
• Is Part Of: Toxicology reports. Volume 7(2020)
• Page Start: 1514
• Page End: 1530
• Publication Date: 2020
• Subjects: Glioma -- Glioblastoma multiforme -- miRNA-21 -- microRNA -- oncomiR; Toxicology -- Periodicals; Clinical toxicology -- Periodicals; Drug-Related Side Effects and Adverse Reactions; Hazardous Substances; Poisoning; Toxicology; Electronic journals; Periodicals; Periodicals; 571.9505
• DOI: 10.1016/j.toxrep.2020.11.001
• Languages: English
• ISSNs: 2214-7500

Abstract

Graphical abstract: Highlights: MIRNA-21 is consistently upregulated in gliomas. It suppresses apoptosis and promotes tumor invasion. It is involved in resistance against chemo- and radiotherapy. Research should focus on inhibiting MiRNA-21 in human brains. Abstract: Gliomas are the most common primary brain tumors in adults. They are generally very resistant to treatment and are therefore associated with negative outcomes. MicroRNAs (miRNAs) are small, non-coding RNA molecules that affect many cellular processes by regulating gene expression and, post-transcriptionally, the translation of mRNAs. MiRNA-21 has been consistently shown to be upregulated in glioma and research has shown that it is involved in a wide variety of biological pathways, promoting tumor cell survival and invasiveness. Furthermore, it has been implicated in resistance to treatment, both against chemotherapy and radiotherapy. In this review, we gathered the existent data on miRNA-21 and gliomas, in terms of its expression levels, association with grade and prognosis, the pathways it involves and its targets in glioma, and finally how it leads to treatment resistance. Furthermore, we discuss how this knowledge could be applied in clinical practice in the years to come. To our knowledge, this is the first review to assess in extent and depth the role of miRNA-21 in gliomas.